Fuxi Huang

518 citations
13 papers · 325 indexed · 1 hit paper · h-index 6
Topics
Lung Cancer Treatments and Mutations (7 papers)Cancer Mechanisms and Therapy (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaAnnals of Oncology
Partner nations
ChinaUnited States

In The Last Decade

Fuxi Huang

13 papers receiving 324 citations

Hit Papers

Lenvatinib Combined With Transarterial Chemoembolization ...2022202620232024202250100150200250

Peers

Fuxi Huang
Comparison fields: 5 of 45
  • Hepatology 237
  • Pathology and Forensic Medicine 111
  • Epidemiology 94
  • Pulmonary and Respiratory Medicine 92
  • Oncology 69
Replace Liangliang Qiao with:
Liangliang Qiao China
Shi-Ming Lin Taiwan
Youen Lin China
Shao‐Liang Zhu China
Joon Suk Kim South Korea
Xuqi Sun China
Emmanouil Emmanouil Greece
Thomas Yau Hong Kong
Ziyu Xun China
Fuxi Huang relative to Liangliang Qiao China Liangliang Qiao's profile →
Citations per field
00.5×1.5×
Liangliang Qiao · 1×
Citations per year

Countries citing papers authored by Fuxi Huang

Since Specialization
Citations

This map shows the geographic impact of Fuxi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxi Huang more than expected).

Fields of papers citing papers by Fuxi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxi Huang. The network helps show where Fuxi Huang may publish in the future.

Co-authorship network of co-authors of Fuxi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxi Huang. A scholar is included among the top collaborators of Fuxi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxi Huang. Fuxi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 4
2 2
3 1
4
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)breakdown →
262
5 11
6 12
7 6
8 3
9 1
10 8
11 4
12
Expression of ERCC1, Bcl-2, MT and their clinical significance in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
4
13 7

About Fuxi Huang

Fuxi Huang is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 13 papers that have together received 325 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (237 citations), Pathology and Forensic Medicine (111 citations) and Cancer Research (45 citations). Fuxi Huang has collaborated with scholars based in China and United States. Frequent co-authors include Rong Tang, Fuliang Li, Liangliang Qiao, Yu Cheng, Wenquan Zhuang, Zhen Huang, Jiping Wang, Guoying Wang, Baogang Peng and Junhui Sun. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026